dexmethylphenidate hydrochloride

FDA Drug Profile — Focalin, Focalin XR, Dexmethylphenidate Hydrochloride Extended-Release, DEXMETHYLPHENIDATE HYDROCHLORIDE, Dexmethylphenidate Hydrochloride

dexmethylphenidate hydrochloride is listed in the FDA National Drug Code directory with 50 NDC codes, marketed under brand names including Focalin, Focalin XR, Dexmethylphenidate Hydrochloride Extended-Release. Available dosage forms: capsule, extended release, tablet.

Drug Details

Generic Name
dexmethylphenidate hydrochloride
Brand Names
Focalin, Focalin XR, Dexmethylphenidate Hydrochloride Extended-Release, DEXMETHYLPHENIDATE HYDROCHLORIDE, Dexmethylphenidate Hydrochloride
Application Number
NDA021278
Sponsor
Societal CDMO Gainesville, LLC
NDC Codes
50
Dosage Forms
CAPSULE, EXTENDED RELEASE, TABLET
Routes
ORAL
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Dexmethylphenidate Hydrochloride Extended-release Capsules is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies (14) ] . Dexmethylphenidate Hydrochloride Extended-release Capsules is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older